Tag: Prescription Drugs
Prognostic Model Developed for Immunotx of Urothelial Cancer
Model, based on six factors, predicts overall survival for patients treated with atezolizumab
Atezolizumab + Bevacizumab Shows Benefit in Met Renal CA
Progression-free survival benefit for patients with untreated metastatic renal cell carcinoma
Apalutamide Active in Castration-Resistant Prostate Cancer
Apalutamide prolongs metastasis-free survival in non-metastatic castration-resistant prostate cancer
Guideline-Directed Medical Tx Adherence Low Post CABG
Compliance higher in PCI than CABG, but remains low in contemporary clinical trials
Glecaprevir-Pibrentasvir Effective Treatment for HCV Genotypes 1, 3
Once-daily treatment for eight or 12 weeks yields high rates of sustained virologic response
Glucagon Underutilized in Prehospital, Emergency Settings
Diabetic problem often incorrectly coded by dispatch; paramedic access to give glucagon also an issue
Pharmacist Education May Cut Junior Doctor Prescription Errors
Regular and targeted feedback by pharmacists reduces Rx errors; effect of e-learning tools unclear
ASA: Combo of BP, Cholesterol Meds Tied to Reduced Stroke Risk
44 percent drop in stroke for those with intermediate CVD risk receiving candesartan/HCTZ, rosuvastatin
Adjunct Zonisamide Beneficial in Dementia With Lewy Bodies
Zonisamide as an adjunct to levodopa improves parkinsonism without worsening cognitive function
Greater Prior Authorization Requirements Seen for PCSK9i Rx
PA requirements are more extensive for PCSK9is than for other cardiometabolic drugs
